The price, and that is confidential & was negotiated for all in all , 300 huge number of doses, is a little less than the $19.50 a photo the United States agreed to pay for a very first shipment of hundred million doses of the identical vaccine, in line with what Reuters claimed in November.
The EU booklet dated Nov. 18 was circulated internally after the EU announced the supply offer of its with Pfizer and its German partner BioNTech on Nov. eleven.
The EU drug regulator is actually anticipated to determine on Monday on endorsement for the Pfizer vaccine following the shot was authorised in a number of countries, like Britain and the United States.
On Thursday Belgian state secretary with the budget Eva De Bleeker released on Twitter a dining room table with costs Belgium would pay pharmaceutical companies for their COVID 19 vaccines. She retracted the post shortly after posting.
In this dining room table the Pfizer vaccine was indicated as costing Belgium 12 euros ($14.6) per dose, top many to believe that was the total cost agreed with the EU.
Other vaccines in the family table were also shown with prices lower than rates disclosed by EU solutions.
“There is , obviously , a complete cost and a price upon delivery,” an EU official involved in talks with vaccine makers told Reuters when asked to clarify the difference between the Belgian and EU rates.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker stated Belgium’s budgeted price tags were still partial.
Underneath EU advanced purchase deals for COVID-19 vaccines, the bloc believes upfront payments with business enterprises to secure doses before they’re approved. Following approvals, EU governments can pay the rest to buy reserved doses.
The EU hasn’t revealed the initial transaction agreed with Pfizer.
However, it stated in October that it paid about 1 billion euros found in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for the shots of theirs, with a further 1.45 billion euros budgeted for initial payments to Pfizer BioNTech, Curevac and Moderna.
It has since agreed supply deals with all six companies and is negotiating a seventh agreement with Novavax.